adagrasib
mirati
['lung', 'krystal-1', 'sclc', 'nsclc', 'adagrasib']
just out at #asco22 krystal-1 in those with previously treated krasg12 mutated #nsclc #lungcancer adagrasib showed clinical efficacy orr 43% pfs 6.5 mo os 12.6 mo grade3 -4 adverse events 43% 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??